v3.26.1
Note 4 - Other Financial Information - Accounts Payable and Accrued Expense (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Accounts payable $ 17,209 $ 12,137
Accrued sales reserves 8,278 6,493
Accrued clinical expenses 2,627 2,364
Accrued research and development expenses 749 886
Accrued selling, general and administrative expenses 4,562 3,903
Accrued other expenses 1,921 1,934
Total accounts payable and accrued expenses $ 35,346 $ 27,717